In Vivo Measurement and Characterization of a Novel Formulation of [177Lu]-DOTA-Octreotate

Objective(s):Lutetium-177 can be made with high specific activity and with no other isotopes of lutetium present, referred to as “No Carrier Added” (NCA) 177Lu. We have radiolabelled DOTA-conjugated peptide DOTA‐(Tyr3)‐octreotate with NCA 177Lu (“NCA-LuTATE”) and used it in nearly 40 therapeutic adm...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Dale Bailey, Thomas Hennessy, Kathy Willowson, Eric Henry, David Chan, Alireza Aslani, Paul Roach
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Mashhad University of Medical Sciences 2016-01-01
Serie:	Asia Oceania Journal of Nuclear Medicine and Biology
Soggetti:	Radionuclide therapy SPECT, lutetium-177 neuro-endocrine tumours
Accesso online:	http://aojnmb.mums.ac.ir/pdf_6232_fa548ac8da236e05068be2fab284051d.html
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!